Pharmaceutical and Biotech Companies - Drug Development Pipelines
Find below the latest pipeline disclosures for major biotechnology and pharmaceutical companies.
When possible I include PDF version to provide a historical record.
Click here for archived data (prior to 2016)
When possible I include PDF version to provide a historical record.
Click here for archived data (prior to 2016)
February 2018 Update: The "Top 11" biotech / pharmaceutical company (based on PharmExec list) pipelines have been updated below based on the most recent disclosures.
Abbvie $ABBV
Allergan $AGN
Amgen $AMGN
Astellas $ALPMY
AstraZeneca / Medimmune $AZN
Bayer Healthcare $BAYRY
Boehringer-Ingelheim (Private)
Bristol Myers Squibb $BMY
Celgene $CELG
Daiichi-Sankyo $DSKYF
Eli Lilly $LLY
Gilead $GILD
GlaxoSmithKline $GSK
Johnson and Johnson / Janssen $JNJ
|
|
Merck $MRK
- Merck R&D pipeline PDF (as of November 2017)
Novartis $NVS
- PDF of Novartis pipeline (as of December 2017)
- 2017 earnings slide deck with pipeline highlights (January 2018)
Pfizer $PFE
- PDF of Pfizer R&D pipeline (January 2018)
- Pfizer website with archived pipeline updates is gone :(
Roche / Genentech $RHHBY
- PDF of Roche / Genentech pipeline (as of October 2017)
- Interactive pipeline webpage (last updated February 2018)
Sanofi / Genzyme $SNY
- PDF of Sanofi pipeline (October 2017)
- Analyst Day slide deck (December 2017)
Teva Pharmaceuticals $TEVA
- Pending